From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches

D Ehninger - Neuropharmacology, 2013 - Elsevier
Tuberous sclerosis (TSC) is a neurocutaneous disorder with an autosomal-dominant pattern
of inheritance and is caused by heterozygous mutations in the TSC1 or TSC2 gene …
被引用次数：84 相关文章

[引用][C] From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches

D Ehninger - Neuropharmacology, 2013 - cir.nii.ac.jp
From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based
treatment approaches | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁[サイニィ] …

From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches

D Ehninger - Neuropharmacology, 2013 - infona.pl
Tuberous sclerosis (TSC) is a neurocutaneous disorder with an autosomal-dominant pattern
of inheritance and is caused by heterozygous mutations in the TSC1 or TSC2 gene …

From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches.

D Ehninger - Neuropharmacology, 2012 - europepmc.org
Tuberous sclerosis (TSC) is a neurocutaneous disorder with an autosomal-dominant pattern
of inheritance and is caused by heterozygous mutations in the TSC1 or TSC2 gene …

From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches

D Ehninger - Neuropharmacology, 2013 - pubmed.ncbi.nlm.nih.gov
Tuberous sclerosis (TSC) is a neurocutaneous disorder with an autosomal-dominant pattern
of inheritance and is caused by heterozygous mutations in the TSC1 or TSC2 gene …